Franz Obermayr
Chief Executive Officer at Panoptes Pharma GmbH
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brian Strem | M | 44 | 3 years | |
| Aron Shapiro | M | 46 | 3 years | |
| Kenneth Gayron | M | 54 | 3 years | |
| David Hollander | M | 50 | 3 years | |
| Eric Daniels | M | 51 | 3 years |
See more
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Thomas Hancock | M | 60 | 14 years | |
| Morton F. Goldberg | M | 86 | 13 years | |
| Bernard Malfroy-Camine | M | 71 | 9 years | |
| Stefan Sperl | M | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | - |
| Illya Keith Maher | M | 56 | 1 years | |
| Steven Boyd | M | 43 | 3 years | |
| Michael P. Manzo | M | 64 | 15 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 11 | 91.67% |
| Austria | 1 | 8.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Franz Obermayr
- Personal Network